Motor and non-motor symptoms in cervical dystonia: a serotonergic perspective

    Research output: ThesisThesis fully internal (DIV)

    1353 Downloads (Pure)


    In this thesis, we detected a high frequency of non motor symptoms (NMS) in patients with cervical dystonia (CD) , with a high impact on quality of life (HR-QoL). Psychiatric co-morbidity and fatigue are most likely primary symptoms and part of the phenotype of CD, while excessive daytime sleepiness and impaired sleep quality were highly related to psychiatric co-morbidity and pain. To improve the recognition and treatment of NMS, we proposed and explored a NMS questionnaire as a first step towards a dystonia specific NMS questionnaire. Future studies are warranted to explore the effect of NMS treatment on HR-QoL.
    Secondly, we explored the role of serotonin in the pathophysiology of dystonia, using PET imaging. It appeared that serotonergic perturbations in the raphe nuclei and in basal ganglia output regions are related to both motor- and NMS in CD.
    Currently, there are no good (pharmaco)therapeutic options for most forms of dystonia or associated non-motor symptoms. Further research using PET imaging or by using selective serotonergic drugs in appropriate models of dystonia is required to establish the role of the serotonergic system in dystonia and to guide us to new therapeutic strategies.
    Original languageEnglish
    QualificationDoctor of Philosophy
    Awarding Institution
    • University of Groningen
    • de Koning-Tijssen, Marina, Supervisor
    • Dierckx, Rudi, Supervisor
    • Bartels, Anna, Co-supervisor
    • de Jong, Bauke, Co-supervisor
    Award date10-May-2017
    Place of Publication[Groningen]
    Print ISBNs978-90-367-9605-7
    Electronic ISBNs978-90-367-9606-4
    Publication statusPublished - 2017

    Cite this